Jump to main content

博士論文

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma

Icons representing 博士論文
The cover of this title could differ from library to library.

Available in National Diet Library

Find on the publisher's website

NDL Digital Collections

Digital data available

Check on the publisher's website

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma

Persistent ID (NDL)
info:ndljp/pid/12969602
Material type
博士論文
Author
舟越, 勇介
Publisher
-
Date granted
2023-03-20
Material Format
Digital
Capacity, size, etc.
-
Degree grantor and degree
九州大学,博士（医学）
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii ResearchLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General)：

PubMed番号 : 33838014

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma
Author/Editor
舟越, 勇介
Author Heading
舟越, 勇介
Publication Date
2023-03-20
Publication Date (W3CDTF)
2023-03-20
Alternative Title
IDH-wildtype glioblastomaにおけるCDKN2Aホモ欠失とMGMTメチル化の臨床的意義
Degree Grantor
九州大学
Date Granted
2023-03-20
Date Granted (W3CDTF)
2023-03-20